Tables
- TABLE 1
Characteristics of COVID-19 patients on continuous positive airway pressure (CPAP) with pulmonary barotrauma: wave 2
Summary Patients receiving CPAP, n 136 Barotrauma cases, n 9 Incidence, % 6.6 Demographics Age, years, median (range) 64 (27–82) Male/female, n 6/3 BMI, kg·m−2, median (range) 28 (24–36) Never-smoker/ex-smoker, n 6/3 Underlying respiratory diagnosis, n None 7 Asthma 1 Pleural plaques 1 Baseline characteristics before commencing CPAP Respiratory rate, breaths·min−1, median (mean; range) 28 (29.5; 20–40)# PaO2/FIO2 ratio, mmHg, median (mean; range) 72 (80.0; 55–122) CPAP therapy Time from commencing CPAP to barotrauma diagnosis, days, median (range) 6 (3–10) Maximum CPAP pressure received, cmH2O, median (range) 12.5 (10–15) Barotrauma cases Bilateral/unilateral pneumothorax, n 4/1 Requirement of intercostal chest drain insertion, n 3 Pneumomediastinum, n 9 Surgical emphysema (radiological diagnosis), n 8 Outcome, n Died 5 Inpatient 1 Discharged 3 COVID-19: coronavirus disease 2019; BMI: body mass index; PaO2: arterial oxygen tension; FIO2: inspiratory oxygen fraction. #: data available for eight out of nine patients.
Vol 7 Issue 4
Table of Contents
Is continuous positive airway pressure therapy in COVID-19 associated with an increased rate of pulmonary barotrauma?
